
Deferoxamine Mesylate
Chemox Pharma is a leading and a top Deferoxamine Mesylate manufacturer in India, supplying high-quality pharmaceutical-grade APIs to global markets. Deferoxamine Mesylate
Emtricitabine [Cas No. 143491-57-0] is a nucleoside reverse transcriptase inhibitor [NRTI] API which is mostly used in treatment of antiviral therapies. Emtricitabine is also known as cytidine analogue and treats HIV-1 infections by inhibiting reverse transcriptase enzyme, resulting in blockage of viral replication and reduces viral load in patients. Emtricitabine API has high efficacy against HIV and hepatitis B virus [HBV] and provides high oral availability and has long shelf life.
Chemox Pharma is a trusted supplier of Emtricitabine with strict quality assurance and supports all global regulatory documents such as WHO-GMP, FDA, DCGI. Chemox Pharma is a reputed manufacturer of high – quality Active Pharmaceutical Ingredients (APIs) and advanced Intermediates with its multipurpose ultramodern state-of-the-art facility at Dahej Industrial area of Gujarat, India. Chemox Pharma pride on delivering innovative, reliable, and competitively priced solutions, ensuring timely delivery to meet the needs of the global pharmaceutical industry.
| Sr. No. | Description | Application |
|---|---|---|
| 1 | Antiretroviral API | HIV treatment formulations |
| 2 | NRTI drug substance | Combination antiretroviral therapy |
| 3 | Antiviral therapeutic ingredient | HIV-1 infection management |
| 4 | Reverse transcriptase inhibitor API | HAART formulations |
| 5 | Nucleoside analogue antiviral | HIV suppression therapy |
Emtricitabine is widely used by pharmaceutical manufacturers in antiretroviral formulations for HIV treatment and prevention therapies.
Emtricitabine API should be handled according to standard pharmaceutical material safety and industrial hygiene procedures. Appropriate protective measures must be followed during handling and processing of the antiviral active pharmaceutical ingredient in GMP manufacturing environments.
Use appropriate personal protective equipment (PPE)
Avoid inhalation of powder and contact with skin or eyes
Handle in controlled pharmaceutical manufacturing areas
Follow GMP material handling procedures
Refer to Safety Data Sheet (SDS) for detailed safety guidance
This API is intended exclusively for pharmaceutical manufacturing and formulation use.
Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) that is phosphorylated intracellularly to its active triphosphate form. It competitively inhibits HIV reverse transcriptase and incorporates into viral DNA, causing chain termination during viral replication. This mechanism suppresses HIV replication and reduces viral load in infected patients.
Handle in approved pharmaceutical manufacturing facilities
Avoid exposure without protective equipment
Prevent dust generation and inhalation
Follow GMP containment procedures
Dispose according to regulatory guidelines
Store in tightly closed containers
Protect from moisture and light
Maintain controlled room temperature
Keep in designated API storage areas
Follow GMP warehouse practices
Emtricitabine API is used in pharmaceutical formulations for the treatment and prevention of HIV infection as part of antiretroviral therapy.
Yes, Chemox Pharma is a WHO-GMP certified Emtricitabine API manufacturer and supplier in India serving global pharmaceutical companies.
The CAS number of Emtricitabine API is 143491-57-0.
Emtricitabine belongs to the nucleoside reverse transcriptase inhibitor (NRTI) class of antiviral agents used in HIV treatment.
It should be stored in tightly closed containers at controlled room temperature, protected from moisture and light, following pharmaceutical storage guidelines.

Chemox Pharma is a leading and a top Deferoxamine Mesylate manufacturer in India, supplying high-quality pharmaceutical-grade APIs to global markets. Deferoxamine Mesylate

Chemical Name: Benfotiamine (S-benzoylthiamine O-monophosphate) CAS Number: 22457-89-2 Molecular Formula: C₁₉H₂₃N₄O₆PS Molecular Weight: 466.45 g/mol Therapeutic Uses: Diabetic neuropathy, neuroprotection, nerve &

API name/end use: Sartan family Cas number: 124750-51-2 Molecular formula: C33H25BrN4 Molecular Weight: 557.48 Appearance: Solid Powder Storage: Room Temperature (Recommended in